Weight Loss in Cancer and Alzheimer's Disease is Mediated by a Similar Pathway.
From: Research Solutions, Philadelphia, PA, USA. JKnittweis@aol.com
Medical hypotheses
- Publish Date: Aug 1999
- ISSN: 0306-9877
- Volume: 53
- Issue: 2
- Pages: 172-4
- Medium: Print
- Language: English
- Citation (JAMA): Knittweis J, et al. Weight Loss in Cancer and Alzheimer's Disease is Mediated by a Similar Pathway.. Med. Hypotheses Aug 1999;53:172-4
Abstract
Weight loss, despite adequate caloric intake, occurs in Alzheimer’s disease and cancer. Similar alterations of biochemistry accompany the weight loss in both diseases, and this suggests a common pathway of weight loss. If this hypothesis is correct, then drugs that prevent weight loss in cancer should also prevent weight loss in Alzheimer’s disease. Megestrol acetate prevents weight loss in human and animal cancers. Omega 3 fatty acids prevent weight loss in animal models of cancer. Both compounds might prevent weight loss in Alzheimer patients.
Mesh Headings (Keywords): Alzheimer Disease, Humans, Models, Biological, Neoplasms, Weight Loss
Check for Full Text / PubMed Unique Identifier (PMID): 10532714
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.